Target intelligence / Profile preview

Reactive oxygen species and organic radicals (ROS) (ROS)

Target
ROS
Molecular classification
Reactive chemical species, Other
01

Overview

Reactive oxygen species (ROS) and organic radicals are highly reactive molecules containing oxygen or carbon with unpaired electrons, primarily generated as byproducts of mitochondrial metabolism and enzymatic activity (Sies et al., 2017). In physiological conditions, they serve as vital signaling molecules regulating cell growth, differentiation, and the immune response (Pizzino et al., 2017). However, excessive accumulation leads to oxidative stress, causing irreversible damage to DNA, proteins, and lipids, which is a key driver in the progression of chronic diseases such as cancer, Alzheimer's, and atherosclerosis (NIH, 2023). Therapeutic targeting involves the use of antioxidants and radical scavengers, such as Edaravone or N-acetylcysteine, to neutralize these species and prevent tissue damage (StatPearls, 2023). Despite their therapeutic potential, non-selective removal of ROS can interfere with necessary cellular signaling pathways, presenting a significant challenge in drug development (Halliwell, 2011). Furthermore, the use of high-dose antioxidants has occasionally been linked to increased mortality or accelerated cancer progression in specific clinical contexts.

Other names
Free radicalsOxidantsOxygen radicalsPro-oxidantsReactive oxygen speciesOrganic free radicals
02

Mechanism of action

Drugs targeting these species typically act through direct scavenging, where they donate electrons to neutralize unpaired electrons, or by acting as mimetics of endogenous antioxidant enzymes like superoxide dismutase and catalase (Sies et al., 2017).

03

Biological functions

Signal transductionImmune responseApoptosisRedox homeostasisOther
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationOther
05

Safety considerations

Disruption of essential physiological redox signaling pathwaysPotential for pro-oxidant activity at high concentrations (antioxidant paradox)Interference with the efficacy of ROS-generating therapies like radiation and certain chemotherapiesImpairment of ROS-dependent immune defenses
06

Interacting drugs

N-acetylcysteine

6 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Protein carbonyls4-Hydroxynonenal (4-HNE)F2-isoprostanes

Beyond the preview

Go deeper on Reactive oxygen species and organic radicals (ROS) (ROS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and organic radicals (ROS) (ROS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call